Hyperglycemia has been identified as the major factor for the development of diabetic microvascular complication including retinopathy. Increased expression of Endothelin -I (ET-1) is associated with diabetic retinopathy and vasculopathy, although the molecular explanation has not been defined. The study was conducted on 55 patients suffering from type 2 diabetes attending the Retina Clinic of Ophthalmology, Research Institute of Ophthalmology, seeking advice as regard eye complications of diabetes. The patients were divided into three groups: Group I included 15 patients who had no retinopathy, Group 11 including 20 patients with non-proliferative diabetic retinopathy of varying severity and Group III including 20 patients with proliferative diabetic retinopathy. Beside 20 healthy, age and sex matched subjects as a control group. The aim of this study was to examine whether ET-l plays a role in the progression of diabetic retinopathy in cooperation with the other inflammatory markers. Also to detect the relationship between the stages of diabetic retinopathy and the inflammatory activity by measuring serum IL-6, CRP, haptoglobin and alpha-I antitrypsin as markers of inflammation. All patients were subjected to the following: detection of plasma levels of glucose and ET-1, serum levels of IL-6, CRP, haptoglobin, a-I antitrypsin, ALT and AST). The results showed that, the plasma level of ET-1 was increased significantly in-Group II and Group III as compared to the control group and the highest level was detected in-Group III. While, the other inflammatory markers (IL-6, CRP, haptoglobin and a-I antitrypsin) its serum levels were increased significantly as compared to the control group. There were statistically significant positive correlation (p